JS

Jo Shen

Venture Partner at Vivo Capital

Saratoga, California

Overview 

Jo Shen is currently a Venture Partner at Vivo Capital, bringing extensive experience from roles such as Co-Founder & CEO at ScinoPharm and Corporate VP at Syntex Pharmaceuticals. With a background in pharmaceuticals and a proven track record in executive leadership, Shen has successfully navigated various stages of company growth and development within the industry.

Work Experience 

T(

TCA (Taiwan CDMO Alliance)

  • Head

    2024 - Current

SB

Steminent Biotherapeutics

  • Independent Board Member

    2024

Senhua Pharma

  • Board Member

    2023

AM

AnHorn Medicines

  • Board Member

    2023

HP

Handa Pharmaceuticals

  • Board Member

    2022

LT

Lumosa Therapeutics Co., Ltd.

  • Independent Board Member

    2021

OP

OBIGEN PHARMA

  • Board Member

    2021

FP

Formosa Pharmaceuticals, Inc.

  • Board Member

    2017

VC

Vivo Capital

  • Venture Partner

    2016

Vivo is a global investment firm focused on healthcare with approximately $5.8 billion in AUM

vivocapital.com
TB

Taiwan Bio Industry Organization (Taiwan BIO)

  • Vice Chairman

    2014

Education 

Articles About Jo

Relevant Websites